Changes in airway cross sectional areas during residual neuromuscular blockade, and after reversal

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519777-19-00

Acronym

AITT 2022/5

Enrollment

Registered

2025-01-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detection of residual neuromuscular blockade after extubation by measuring upper airway diameter

Brief summary

The differences in retroglossal pharyngeal cross sectional areas (inspiration and exspiration) measured at different TOF values

Interventions

DRUGSugammadex Amomed 100 mg/ml solution for injection

DRUGEsmeron 10 mg/ml oldatos injekció

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
The differences in retroglossal pharyngeal cross sectional areas (inspiration and exspiration) measured at different TOF values	—

Countries

Hungary

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026